arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Evolent Health, Inc.

EVH
$3.97 ▲ +0.38 (+10.58%) at close
Industrials ·Services-Management Services ·USServices-Management Services
14 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
12
Health
Poor
Bearish
auto_awesome

Analytical Summary

Evolent Health, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $453.4M
Dividend Yield
Revenue Growth -26.6%
Op. Margin -21.9%
ROIC -29.6%
FCF / Share $0.34
Trailing P/E
Price / Book 1.1x
FCF Yield 8.6%
Debt / Equity 2.34
info Valuation on last close. End-of-day price, Aug 7, 2026.

14-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.88B
↓ -26.6%
Net Income Profit after all expenses
$-534.51M
↓ -767.4%
Operating Margin Operating profit as % of sales
-21.9%
↓ -1279.4% 9th
FCF / Share Free cash flow per share
$0.34
↑ +107.9%
Long-Term Debt Long-term obligations
$970.54M
↑ +97.9%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
17
Returns
6
Financial Health
11
Cash Quality
19

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 51 quarters